Wednesday, January 12, 2022 12:10:01 UTC
In 2022, Covid will not be the world's top public enemy. Inflation and the likelihood that policymakers dismiss the post-Covid rebound will be the major threats this year.
For most of 2021, policymakers at the Federal Reserve and many other central banks were confident in dismissing labor shortages and supply-chain bottlenecks as pandemic side effects. Lingering fear of Covid and those extra federal dollars in bank accounts were discouraging many of the unemployed from returning to work. The central banks reasoned that given enough time, these difficulties would be resolved.
President Biden and his White House have not solved either issue.
The pandemic may have permanently altered the way we work and shop, but after the virus has been eradicated, the basic dynamics of demand and supply will swiftly return to normal. Then inflation will begin to return to the Federal Reserve's long-term target of 2%. If they're correct, officials will have avoided a recession by guiding the US economy to a smooth landing. If they are wrong, we shall all pay the price in 2023.(More)
@pfizerinc @moderna_tx @pfizerinc @moderna_tx
#pfe #mrna #pfizerinc #pfizer #moderna #vaccine #covid #inflation #federalreserve #joebide
Wed, Jan 5, 22
More Covid woes: Fed Reserve
Mon, Dec 20, 21
Novavax approved for emergency use
Mon, Dec 20, 21
Stocks fall after Manchin BBB shocker
Mon, Dec 13, 21
Pfizer to buy Arena Pharmaceuticals $6.7B
Thu, Dec 9, 21
World markets cool off
Wed, Jan 5, 22
More Covid woes: Fed Reserve
Mon, Dec 20, 21
Novavax approved for emergency use
Mon, Dec 20, 21
Stocks fall after Manchin BBB shocker
Mon, Dec 13, 21
Pfizer to buy Arena Pharmaceuticals $6.7B
Thu, Dec 9, 21
World markets cool off
Wednesday, January 05, 2022 14:58:10 UTC
The newest COVID-19 wave is reducing labor supply, leading the Federal Reserve to conclude that employment is approaching its practical limits.
Reports indicate a slowdown in hiring at front-line enterprises and a record number of Americans quitting their jobs. Employment dipped in December, according to statistics compiled by company payroll managers Homebase and UKG, coinciding with a record incidence of coronavirus illnesses caused by the Omicron type.(More)
Wednesday, January 05, 2022 14:58:10 UTC
The newest COVID-19 wave is reducing labor supply, leading the Federal Reserve to conclude that employment is approaching its practical limits.
Reports indicate a slowdown in hiring at front-line enterprises and a record number of Americans quitting their jobs. Employment dipped in December, according to statistics compiled by company payroll managers Homebase and UKG, coinciding with a record incidence of coronavirus illnesses caused by the Omicron type.
#mrna #pfe #ccl #spy #modernainc #moderna #pfizer #vaccine #covid #omicron
Monday, December 20, 2021 12:57:10 UTC
With an emergency approval for use by the WHO, Novavax is ripping in premarket, and options have been historically adjusting very well for this stock.
The stock increased after World Health Organization granted the vaccine company and the Serum Institute of India an emergency use authorization for their Covid-19 vaccine.
Covovax, which is manufactured and marketed by the Serum Institute for India and other developing nations, has been awarded emergency use status by the WHO.
Novavax's Covid-19 vaccine is protein-based, unlike the vaccines developed by the Pfizer (PFE) and BioNTech (BNTX) alliance and Moderna (MRNA), which are based on messenger RNA drug technology.
NOTE: This is not an endorsement or rejection of vaccines. This is a stock market news item.(More)
Monday, December 20, 2021 12:57:10 UTC
With an emergency approval for use by the WHO, Novavax is ripping in premarket, and options have been historically adjusting very well for this stock.
The stock increased after World Health Organization granted the vaccine company and the Serum Institute of India an emergency use authorization for their Covid-19 vaccine.
Covovax, which is manufactured and marketed by the Serum Institute for India and other developing nations, has been awarded emergency use status by the WHO.
Novavax's Covid-19 vaccine is protein-based, unlike the vaccines developed by the Pfizer (PFE) and BioNTech (BNTX) alliance and Moderna (MRNA), which are based on messenger RNA drug technology.
NOTE: This is not an endorsement or rejection of vaccines. This is a stock market news item.
12.20.21 12:33 PM UTC
Stocks responded negatively in pre-market today when Sen. Mancin rejected Biden's Build Back Better plan Sunday with a sarcastic comment about its flaws.
Monday, December 20, 2021 12:33:45 UTC
Stocks responded negatively in pre-market today when Sen. Mancin rejected Biden's Build Back Better plan Sunday with a sarcastic comment about its flaws.
#moderna #pfizer #vaccine #covid #omicron #buildbackbetter #joebiden #joemanchin
12.13.21 12:07 PM UTC
Pfizer has agreed to cash buy Arena Pharmaceuticals in a deal with a value of about $6.7 billion. The announcement bolstered Arena shares (ARNA) by 91% in premarket.
Monday, December 13, 2021 12:07:25 UTC
Pfizer has agreed to cash buy Arena Pharmaceuticals in a deal with a value of about $6.7 billion. The announcement bolstered Arena shares (ARNA) by 91% in premarket.
#pfizer #arenapharmaceuticals #covid #vaccine #premarket #crohnsdisease
12.8.21 1:03 PM UTC
Pfizer and BioNTech have announced a two-shot vaccine, plus a third booster was able to neutralize the new Omicron variant, and could be ready by March 2022.
Wednesday, December 08, 2021 13:03:58 UTC
Pfizer and BioNTech have announced a two-shot vaccine, plus a third booster was able to neutralize the new Omicron variant, and could be ready by March 2022.
#pfizer #biontech #omicron #covid #americanairlines #booster #vaccine
12.7.21 11:57 AM UTC
Moderna Inc. dropped more than 13% last night earning the title of worst performing stock in the S&P 500. Just last week it topped the same benchmark.
Tuesday, December 07, 2021 11:57:27 UTC
Moderna Inc. dropped more than 13% last night earning the title of worst performing stock in the S&P 500. Just last week it topped the same benchmark.
#moderna #mrna #covid #vaccine #pfizer #omicron #berniesanders
12.6.21 12:58 PM UTC
Cases of the latest Covid variant, omicron have been identified in a third of all U.S. states. The FDA looks to expedite authorization for modified vaccines.
Monday, December 06, 2021 12:58:13 UTC
Cases of the latest Covid variant, omicron have been identified in a third of all U.S. states. The FDA looks to expedite authorization for modified vaccines.
#covid #pfizer #pfe #biontech #bntc #moderna #mrna #vaccine #omicron
12.3.21 3:22 PM UTC
The US Labor Department reported today that payrolls in November were up by just 210,000, far below the 550,000 jobs forecast.
Friday, December 03, 2021 15:22:14 UTC
The US Labor Department reported today that payrolls in November were up by just 210,000, far below the 550,000 jobs forecast.
#unemployed #covid #jobless #omicron #panic #pfizer #moderna